, Tracking Stock Market Picks
Enter Symbol:
Prana Biotechnology Ltd (PRAN) [hlAlert]

Mkt Outperform
down 61.30 %

Prana Biotechnology Ltd (PRAN) rated Mkt Outperform with price target $5 by Burrill Institutional Research

Posted on: Thursday,  Dec 20, 2012  8:25 AM ET by Burrill Institutional Research

Burrill Institutional Research rated Mkt Outperform Prana Biotechnology Ltd (NASDAQ: PRAN) on 12/20/2012, when the stock price was $2.30.
Since then, Prana Biotechnology Ltd has lost 61.30% as of 12/23/2015's recent price of $0.89.
If you would have followed this Burrill Institutional Research's recommendation on PRAN, you would have lost 61.3% of your investment in 1098 days.

Prana Biotechnology Limited (Prana) is a development-stage company at an early stage in the development of its pharmaceutical products that are designed to treat the underlying causes of degeneration of the brain and the eye as the aging process progresses. Other potential applications for the Company?s therapies include Huntington?s disease, Parkinson?s disease, certain cancers, age-related macular degeneration, Motor Neuron disease, Creutzfeldt-Jakob disease (the human variant of Mad Cow disease) and age-related cataracts. The Company has two wholly owned subsidiaries, Prana Biotechnology Inc. and Prana Biotechnology UK Limited. Prana?s activities are focused within Australia and cover research into Alzheimer?s disease and other age-related degenerative disorders.

Burrill Institutional Research
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/20/2012 8:25 AM Buy
2.30 5.00
as of 12/31/2012
1 Week up  1.38 %
1 Month down  -4.34 %
3 Months   
1 YTD down  -4.34 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy